Idiopathic Pulmonary Fibrosis: Prevailing and Evolving Hypotheses about Its Pathogenesis and Implications for Therapy
暂无分享,去创建一个
[1] M. Turner-Warwick,et al. Precapillary Systemic-pulmonary Anastomoses , 1963, Thorax.
[2] R. H. Ellis. Familial Incidence of Diffuse Interstitial Pulmonary Fibrosis , 1965, Postgraduate medical journal.
[3] M. Jayson,et al. Biosynthesis and maturation of skin collagen in scleroderma, and effect of D-penicillamine. , 1974, Lancet.
[4] J. Yernault,et al. Pulmonary mechanics in diffuse fibrosing alveolitis. , 1975, Bulletin de physio-pathologie respiratoire.
[5] N. Pride,et al. Lung distensibility. The static pressure-volume curve of the lungs and its use in clinical assessment. , 1976, British journal of diseases of the chest.
[6] D. Geddes,et al. α1-ANTITRYPSIN PHENOTYPES IN FIBROSING ALVEOLITIS AND RHEUMATOID ARTHRITIS , 1977, The Lancet.
[7] R G Gupta,et al. Natural history and treated course of usual and desquamative interstitial pneumonia. , 1978, The New England journal of medicine.
[8] R. Crystal,et al. Distribution of HLA antigens in idiopathic pulmonary fibrosis. , 2015, The American review of respiratory disease.
[9] M. Warwick,et al. HLA IN CRYPTOGENIC FIBROSING ALVEOLITIS , 1978, The Lancet.
[10] A. Theofilopoulos,et al. Circulating immune complexes in the idiopathic interstitial pneumonias. , 1978, The New England journal of medicine.
[11] M. Schwarz,et al. Immunofluorescent patterns in the idiopathic interstitial pneumonias. , 1978, The Journal of laboratory and clinical medicine.
[12] A. Jones,et al. Gallium-67 citrate scanning in the staging of idiopathic pulmonary fibrosis: Correlation and physiologic and morphologic features and bronchoalveolar lavage. , 1978, The American review of respiratory disease.
[13] J D Fulmer,et al. Morphologic-physiologic correlates of the severity of fibrosis and degree of cellularity in idiopathic pulmonary fibrosis. , 1979, The Journal of clinical investigation.
[14] J. Meier-Sydow,et al. [Long-term follow-up of lung function parameters in patients with idiopathic pulmonary fibrosis treated with prednisone and azathioprin or d-penicillamine (author's transl)]. , 1979, Praxis und Klinik der Pneumologie.
[15] E. Holborow,et al. Circulating immune complexes in patients with cryptogenic fibrosing alveolitis. , 1979, Clinical and experimental immunology.
[16] N. Pride,et al. Exponential description of the static pressure-volume curve of normal and diseased lungs. , 2015, The American review of respiratory disease.
[17] P. Friedman,et al. Chest radiography in desquamative interstitial pneumonitis: a review of 37 patients. , 1980, AJR. American journal of roentgenology.
[18] B. Burrows,et al. Cryptogenic fibrosing alveolitis: clinical features and their influence on survival , 1980, Thorax.
[19] A. Salsbury,et al. Bronchoalveolar lavage in pulmonary fibrosis: comparison of cells obtained with lung biopsy and clinical features , 1980, Thorax.
[20] A. Salsbury,et al. Bronchoalveolar lavage fluid cell counts in cryptogenic fibrosing alveolitis and their relation to therapy. , 1980, Thorax.
[21] A. Murphy,et al. Familial fibrosing alveolitis , 1981, Irish journal of medical science.
[22] K. Pinsker,et al. Usual interstitial pneumonia following Texas A2 influenza infection. , 1981, Chest.
[23] V. Ferrans,et al. Interstitial lung disease: current concepts of pathogenesis, staging and therapy. , 1981, The American journal of medicine.
[24] W. Roberts,et al. Characterization of the inflammatory and immune effector cells in the lung parenchyma of patients with interstitial lung disease. , 2015, The American review of respiratory disease.
[25] R. Rudd,et al. Cryptogenic fibrosing alveolitis. Relationships of pulmonary physiology and bronchoalveolar lavage to response to treatment and prognosis. , 1981, The American review of respiratory disease.
[26] E. Bauer,et al. Colchicine-induced modulation of collagenase in human skin fibroblast cultures. I. Stimulation of enzyme synthesis in normal cells. , 1982, The Journal of investigative dermatology.
[27] Rosenberger Dm. Inherited forms of interstitial lung disease. , 1982 .
[28] V. Ferrans,et al. Structure of alveolar epithelial cells in patients with fibrotic lung disorders. , 1982, Laboratory investigation; a journal of technical methods and pathology.
[29] R. Crystal,et al. Alveolitis: the key to the interstitial lung disorders. , 1982, Thorax.
[30] J. Milic-Emili,et al. The pattern of breathing in diffuse lung fibrosis. , 1982, Bulletin europeen de physiopathologie respiratoire.
[31] D. Libby,et al. Immunogenetic and clinical findings in idiopathic pulmonary fibrosis. Association with the B-cell alloantigen HLA-DR2. , 2015, The American review of respiratory disease.
[32] H. Reynolds,et al. Bronchial lavage in inflammatory lung disease. , 1983, Clinics in chest medicine.
[33] W. Ward,et al. Collagen accumulation in irradiated rat lung: modification by D-penicillamine. , 1983, Radiology.
[34] J. Vergnon,et al. CRYPTOGENIC FIBROSING ALVEOLITIS AND EPSTEIN-BARR VIRUS: AN ASSOCIATION? , 1984, The Lancet.
[35] G. Raghu,et al. Extracellular matrix in normal and fibrotic human lungs. , 1985, The American review of respiratory disease.
[36] M. Kamboh,et al. Genetic studies in familial fibrosing alveolitis. Possible linkage with immunoglobulin allotypes (Gm). , 1986, Chest.
[37] R. Crystal,et al. Familial idiopathic pulmonary fibrosis. Evidence of lung inflammation in unaffected family members. , 1986, The New England journal of medicine.
[38] R. Chapela,et al. Concentration, biosynthesis and degradation of collagen in idiopathic pulmonary fibrosis. , 1986, Thorax.
[39] H. Chapman,et al. Abnormalities in pathways of alveolar fibrin turnover among patients with interstitial lung disease. , 1986, The American review of respiratory disease.
[40] J. Last,et al. D-penicillamine prevents collagen accumulation in lungs of rats given bleomycin. , 1986, Chest.
[41] L. Watters. Genetic Aspects of Idiopathic Pulmonary Fibrosis and Hypersensitivity Pneumonitis , 1986 .
[42] B. Rabin,et al. Lymphocyte phenotypes in bronchoalveolar lavage and lung tissue in sarcoidosis and idiopathic pulmonary fibrosis. , 1986, The American review of respiratory disease.
[43] M. Turner-Warwick,et al. The value of serial bronchoalveolar lavages in assessing the clinical progress of patients with cryptogenic fibrosing alveolitis. , 1987, The American review of respiratory disease.
[44] M. Schwarz,et al. Idiopathic pulmonary fibrosis. Pretreatment bronchoalveolar lavage cellular constituents and their relationships with lung histopathology and clinical response to therapy. , 1987, The American review of respiratory disease.
[45] L. de Leij,et al. Expression of class II major histocompatibility complex antigens on alveolar epithelium in interstitial lung disease: relevance to pathogenesis of idiopathic pulmonary fibrosis. , 1987, Journal of clinical pathology.
[46] N. Müller,et al. A comparison of bronchiolitis obliterans with organizing pneumonia, usual interstitial pneumonia, and small airways disease. , 2015, The American review of respiratory disease.
[47] G. Hunninghake,et al. Prognostic role of eosinophils in pulmonary fibrosis. , 1987, Chest.
[48] J. Seltzer,et al. H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. , 1988, The Journal of biological chemistry.
[49] R. Crystal,et al. Colchicine suppresses the release of fibroblast growth factors from alveolar macrophages in vitro. The basis of a possible therapeutic approach ot the fibrotic disorders. , 1988, The American review of respiratory disease.
[50] I. Adamson,et al. Relationship of alveolar epithelial injury and repair to the induction of pulmonary fibrosis. , 1988, The American journal of pathology.
[51] J. Darbyshire,et al. Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis. , 1989, Thorax.
[52] N L Müller,et al. Chronic diffuse infiltrative lung disease: comparison of diagnostic accuracy of CT and chest radiography. , 1989, Radiology.
[53] A. Burkhardt,et al. Alveolitis and collapse in the pathogenesis of pulmonary fibrosis. , 1989, The American review of respiratory disease.
[54] T. King,et al. An immunohistochemical study of architectural remodeling and connective tissue synthesis in pulmonary fibrosis. , 1989, The American review of respiratory disease.
[55] A. Eisen,et al. SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. , 1989, The Journal of biological chemistry.
[56] E. Alton,et al. Advanced cryptogenic fibrosing alveolitis: preliminary report on treatment with cyclosporin A. , 1989, Respiratory medicine.
[57] R. Crystal,et al. Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis. , 1989, The American review of respiratory disease.
[58] E. Crouch,et al. Pathobiology of pulmonary fibrosis. , 1990, The American journal of physiology.
[59] D. Bassett,et al. Influenza virus infection, ozone exposure, and fibrogenesis. , 1990, The American review of respiratory disease.
[60] J. Schittny,et al. Molecular architecture of basement membranes , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[61] M. Selman,et al. Platelet-derived growth factor in idiopathic pulmonary fibrosis. , 1990, The Journal of clinical investigation.
[62] S. Peyrol,et al. Intra-alveolar fibrosis of idiopathic bronchiolitis obliterans-organizing pneumonia. Cell-matrix patterns. , 1990, The American journal of pathology.
[63] A. Cantin,et al. Extracellular glutathione suppresses human lung fibroblast proliferation. , 1990, American journal of respiratory cell and molecular biology.
[64] A. Raap,et al. Three sensitive methods for the detection of cytomegalovirus in lung tissue of patients with interstitial pneumonitis. , 1990, American journal of clinical pathology.
[65] I. D. Johnston,et al. What causes cryptogenic fibrosing alveolitis? A case-control study of environmental exposure to dust. , 1990, BMJ.
[66] G. Jakab. Sequential virus infections, bacterial superinfections, and fibrogenesis. , 1990, The American review of respiratory disease.
[67] P. Grenier,et al. Chronic diffuse interstitial lung disease: diagnostic value of chest radiography and high-resolution CT. , 1991, Radiology.
[68] D. Voelker,et al. Idiopathic pulmonary fibrosis. Abnormalities in the bronchoalveolar lavage content of surfactant protein A. , 1991, The American review of respiratory disease.
[69] J. McDonald,et al. The roles of the myofibroblast in idiopathic pulmonary fibrosis. Ultrastructural and immunohistochemical features of sites of active extracellular matrix synthesis. , 1991, The American journal of pathology.
[70] G. Raghu,et al. Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective double-blind, randomized, placebo-controlled clinical trial. , 1991, The American review of respiratory disease.
[71] K. Flanders,et al. Increased production and immunohistochemical localization of transforming growth factor-beta in idiopathic pulmonary fibrosis. , 1991, American journal of respiratory cell and molecular biology.
[72] K. Ohta,et al. Idiopathic pulmonary fibrosis and high prevalence of serum antibodies to hepatitis C virus. , 1992, The American review of respiratory disease.
[73] A. Molteni,et al. Radiation pneumotoxicity in rats: modification by inhibitors of angiotensin converting enzyme. , 1992, International journal of radiation oncology, biology, physics.
[74] N L Müller,et al. Fibrosing alveolitis: chest radiography and CT as predictors of clinical and functional impairment at follow-up in 26 patients. , 1992, Radiology.
[75] H. Itoh,et al. Usual interstitial pneumonia: histologic correlation with high-resolution CT. , 1992, Radiology.
[76] H. Birkedal‐Hansen,et al. Matrix metalloproteinases: a review. , 1993, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.
[77] N. Müller,et al. Subacute and chronic bird breeder hypersensitivity pneumonitis: sequential evaluation with CT and correlation with lung function tests and bronchoalveolar lavage. , 1993, Radiology.
[78] K. Aisaka,et al. Effects of gamma-interferon on collagen and histamine content in bleomycin-induced lung fibrosis in rats. , 1993, Lymphokine and cytokine research.
[79] J. Remy,et al. Importance of ground-glass attenuation in chronic diffuse infiltrative lung disease: pathologic-CT correlation. , 1993, Radiology.
[80] I. D. Johnston,et al. Idiopathic pulmonary fibrosis and hepatitis C virus infection. , 1993, The American review of respiratory disease.
[81] P. McLaughlin,et al. Expression of tumour necrosis factor‐α in cryptogenic fibrosing alveolitis , 1993, Histopathology.
[82] R. Chapela,et al. Mortality in Mexican patients with chronic pigeon breeder's lung compared with those with usual interstitial pneumonia. , 1993, The American review of respiratory disease.
[83] P. McLaughlin,et al. Expression of tumour necrosis factor-alpha in cryptogenic fibrosing alveolitis. , 1993, Histopathology.
[84] J. McDougall,et al. Colchicine in the treatment of pulmonary fibrosis. , 1993, Chest.
[85] M. Akira,et al. Idiopathic pulmonary fibrosis: progression of honeycombing at thin-section CT. , 1993, Radiology.
[86] D. Hansell,et al. Accuracy of the typical computed tomographic appearances of fibrosing alveolitis. , 1993, Thorax.
[87] W. Black,et al. The epidemiology of interstitial lung diseases. , 1994, American journal of respiratory and critical care medicine.
[88] P. Lipsky,et al. Comparative inhibitory effects of bucillamine and D-penicillamine on the function of human B cells and T cells. , 1994, Arthritis and rheumatism.
[89] M. Peão,et al. Neoformation of blood vessels in association with rat lung fibrosis induced by bleomycin , 1994, The Anatomical record.
[90] D. Schwartz,et al. Determinants of survival in idiopathic pulmonary fibrosis. , 1994, American journal of respiratory and critical care medicine.
[91] A. Molteni,et al. Captopril Inhibits Proliferation of Human Lung Fibroblasts in Culture: A Potential Antifibrotic Mechanism , 1994, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[92] P. Howard,et al. Hypothesis: exposure to solvents may cause fibrosing alveolitis. , 1994, The European respiratory journal.
[93] I. Adamson,et al. Fibroblast inhibition does not promote normal lung repair after hyperoxia. , 1994, Experimental lung research.
[94] L. Frank,et al. Effects of the 21‐aminosteroid, U74389F, on bleomycin‐induced pulmonary fibrosis in rats , 1994, Critical care medicine.
[95] M. Yamaguchi,et al. Idiopathic pulmonary fibrosis. Epidemiologic approaches to occupational exposure. , 1994, American journal of respiratory and critical care medicine.
[96] G. Raghu,et al. Idiopathic Pulmonary Fibrosis: Current Clinical Concepts and Challenges in Management , 1994 .
[97] A. Desmoulière,et al. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. , 1995, The American journal of pathology.
[98] A. Fine,et al. Potential therapeutic initiatives for fibrogenic lung diseases. , 1995, Chest.
[99] A. Desmoulière,et al. Cytoskeletal protein modulation in pulmonary alveolar myofibroblasts during idiopathic pulmonary fibrosis. Possible role of transforming growth factor beta and tumor necrosis factor alpha. , 1995, American journal of respiratory and critical care medicine.
[100] M. Selman,et al. Fibroblasts isolated after fibrotic lung injury induce apoptosis of alveolar epithelial cells in vitro. , 1995, The American journal of physiology.
[101] M. Burdick,et al. Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin E2 and to express cyclooxygenase-2. , 1995, The Journal of clinical investigation.
[102] T. Urano,et al. Increased procoagulant and antifibrinolytic activities in the lungs with idiopathic pulmonary fibrosis. , 1995, Thrombosis research.
[103] A. Woodcock,et al. Epstein-Barr virus replication within pulmonary epithelial cells in cryptogenic fibrosing alveolitis. , 1995, Thorax.
[104] J. Sznajder,et al. Increased expression of gelatinases and collagenase in rat lungs exposed to 100% oxygen. , 1996, American journal of respiratory and critical care medicine.
[105] R. Hubbard,et al. Occupational exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitis , 1996, The Lancet.
[106] E. Amento,et al. Relaxin induces an extracellular matrix-degrading phenotype in human lung fibroblasts in vitro and inhibits lung fibrosis in a murine model in vivo. , 1996, The Journal of clinical investigation.
[107] R. Deterding,et al. Keratinocyte growth factor reduces lung damage due to acid instillation in rats. , 1996, American journal of respiratory cell and molecular biology.
[108] B. Monia,et al. Antisense Oligonucleotides Demonstrate a Dominant Role of c-Ki-RAS Proteins in Regulating the Proliferation of Diploid Human Fibroblasts* , 1996, The Journal of Biological Chemistry.
[109] L. Liotta,et al. Immunohistochemical study of metalloproteinases and their tissue inhibitors in the lungs of patients with diffuse alveolar damage and idiopathic pulmonary fibrosis. , 1996, The American journal of pathology.
[110] J. Samet,et al. Corticosteroids and the treatment of idiopathic pulmonary fibrosis. Past, present, and future. , 1996, Chest.
[111] L. Lund,et al. Impaired wound healing in mice with a disrupted plasminogen gene , 1996, Nature Medicine.
[112] K. Flanders,et al. TGF-beta 1, but not TGF-beta 2 or TGF-beta 3, is differentially present in epithelial cells of advanced pulmonary fibrosis: an immunohistochemical study. , 1996, American journal of respiratory cell and molecular biology.
[113] K. Kuwano,et al. P21Waf1/Cip1/Sdi1 and p53 expression in association with DNA strand breaks in idiopathic pulmonary fibrosis. , 1996, American journal of respiratory and critical care medicine.
[114] R. D. McCoy,et al. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. , 1996, The Journal of clinical investigation.
[115] N. Müller,et al. Disease progression in usual interstitial pneumonia compared with desquamative interstitial pneumonia. Assessment with serial CT. , 1996, Chest.
[116] R. McFadden. Surfactant protein A predicts survival in idiopathic pulmonary fibrosis. , 1996, American journal of respiratory and critical care medicine.
[117] Hideki Ito,et al. Interferon-β, an autocrine cytokine, suppresses human fetal skin fibroblast migration into a denuded area in a cell monolayer but is not involved in the age-related decline of cell migration , 1996, Mechanisms of Ageing and Development.
[118] G. Haroske,et al. Alterations in the alveolar epithelium after injury leading to pulmonary fibrosis. , 1996, Histology and histopathology.
[119] R. G. Parrish,et al. Pulmonary fibrosis deaths in the United States, 1979-1991. An analysis of multiple-cause mortality data. , 1996, American journal of respiratory and critical care medicine.
[120] T. Ulich,et al. Keratinocyte growth factor ameliorates radiation- and bleomycin-induced lung injury and mortality. , 1996, The American journal of pathology.
[121] L. Fasano,et al. Incidence of hepatitis C virus infection in Italian patients with idiopathic pulmonary fibrosis. , 1996, Thorax.
[122] J A Waldron,et al. Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. , 1997, American journal of respiratory and critical care medicine.
[123] J. Sznajder,et al. Lung alveolar epithelial cells synthesize interstitial collagenase and gelatinases A and B in vitro. , 1997, The international journal of biochemistry & cell biology.
[124] D. Hansell,et al. Functional impairment in fibrosing alveolitis: relationship to reversible disease on thin section computed tomography. , 1997, The European respiratory journal.
[125] Paul Martin,et al. Wound Healing--Aiming for Perfect Skin Regeneration , 1997, Science.
[126] K. Csaky,et al. Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung. , 1997, The Journal of clinical investigation.
[127] A. Desmoulière,et al. Apoptosis during wound healing, fibrocontractive diseases and vascular wall injury. , 1997, The international journal of biochemistry & cell biology.
[128] D. Hansell,et al. Functional impairment in lone cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a comparison. , 1997, American journal of respiratory and critical care medicine.
[129] R. Whyte,et al. The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis. , 1997, Journal of immunology.
[130] D. Gomez,et al. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. , 1997, European journal of cell biology.
[131] M. Selman,et al. Upregulation of acidic fibroblast growth factor during development of experimental lung fibrosis. , 1997, The American journal of physiology.
[132] T. Urano,et al. Tissue factor expression and fibrin deposition in the lungs of patients with idiopathic pulmonary fibrosis and systemic sclerosis. , 1997, American journal of respiratory and critical care medicine.
[133] C. Vogelmeier,et al. Antioxidative and clinical effects of high-dose N-acetylcysteine in fibrosing alveolitis. Adjunctive therapy to maintenance immunosuppression. , 1997, American journal of respiratory and critical care medicine.
[134] R. Hubbard,et al. Alpha1-antitrypsin phenotypes in patients with cryptogenic fibrosing alveolitis: a case-control study. , 1997, The European respiratory journal.
[135] Y. Açil,et al. Antiinflammatory and Antifibrotic Properties of Colchicine: Implications for Idiopathic Pulmonary Fibrosis , 1997, Lung.
[136] V. Cottin,et al. Respiratory bronchiolitis in smokers with spontaneous pneumothorax. , 1998, The European respiratory journal.
[137] R. Chapela,et al. Colchicine, D-penicillamine, and prednisone in the treatment of idiopathic pulmonary fibrosis: a controlled clinical trial. , 1998, Chest.
[138] J. Iredale,et al. Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. , 1998, The Journal of clinical investigation.
[139] S. Swensen,et al. Colchicine versus prednisone in the treatment of idiopathic pulmonary fibrosis. A randomized prospective study. Members of the Lung Study Group. , 1998, American journal of respiratory and critical care medicine.
[140] V. Cottin,et al. Nonspecific interstitial pneumonia. Individualization of a clinicopathologic entity in a series of 12 patients. , 1998, American journal of respiratory and critical care medicine.
[141] J. Myers,et al. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. , 1998, American journal of respiratory and critical care medicine.
[142] Y. Fukuda,et al. Immunohistochemical and gelatin zymography studies for matrix metalloproteinases in bleomycin‐induced pulmonary fibrosis , 1998, Pathology international.
[143] I. D. Johnston,et al. Exposure to commonly prescribed drugs and the etiology of cryptogenic fibrosing alveolitis: a case-control study. , 1998, American journal of respiratory and critical care medicine.
[144] K P Offord,et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. , 1998, American journal of respiratory and critical care medicine.
[145] M A Schork,et al. Idiopathic pulmonary fibrosis: predicting response to therapy and survival. , 1998, American journal of respiratory and critical care medicine.
[146] Q. Sang,et al. Complex role of matrix metalloproteinases in angiogenesis , 1998, Cell Research.
[147] G. Raghu,et al. Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis. , 1998, American journal of respiratory and critical care medicine.
[148] J. Renauld,et al. Role of interleukin-10 in the lung response to silica in mice. , 1998, American journal of respiratory cell and molecular biology.
[149] W. F. Hughes,et al. Alveolar epithelial cell death adjacent to underlying myofibroblasts in advanced fibrotic human lung. , 1998, American journal of physiology. Lung cellular and molecular physiology.
[150] C. Baecher-Allan,et al. Cell-specific gene expression reveals changes in epithelial cell populations after bleomycin treatment. , 1998, Laboratory investigation; a journal of technical methods and pathology.
[151] M. Kitaichi,et al. Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases. , 1998, Laboratory investigation; a journal of technical methods and pathology.
[152] G. Filippatos,et al. Captopril inhibits apoptosis in human lung epithelial cells: a potential antifibrotic mechanism. , 1998, The American journal of physiology.
[153] A. Baker,et al. Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis. , 1998, The Journal of clinical investigation.
[154] R. Prescott,et al. Thoracic Society study of cryptogenic fibrosing alveolitis : current presentation and initial management , 1998 .
[155] M. Selman,et al. Human lung myofibroblast-derived inducers of alveolar epithelial apoptosis identified as angiotensin peptides. , 1999, The American journal of physiology.
[156] Thiennu H. Vu,et al. Matrix‐degrading proteases and angiogenesis during development and tumor formation , 1999, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[157] V. Petkov,et al. A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. , 1999, The New England journal of medicine.
[158] S. Iyer,et al. Effects of pirfenidone on transforming growth factor-beta gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis. , 1999, The Journal of pharmacology and experimental therapeutics.
[159] B. Society,et al. The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults. Introduction. , 1999, Thorax.
[160] K. S. Lee,et al. Nonspecific interstitial pneumonia with fibrosis: serial high-resolution CT findings with functional correlation. , 1999, AJR. American journal of roentgenology.
[161] M. Burdick,et al. Neutralization of the CXC chemokine, macrophage inflammatory protein-2, attenuates bleomycin-induced pulmonary fibrosis. , 1999, Journal of immunology.
[162] A. Kuijpers-Jagtman,et al. Effects of interferons on proliferation and collagen synthesis of rat palatal wound fibroblasts. , 1999, Archives of oral biology.
[163] V. Polunovsky,et al. Lovastatin induces fibroblast apoptosis in vitro and in vivo. A possible therapy for fibroproliferative disorders. , 1999, American journal of respiratory and critical care medicine.
[164] D A Lynch,et al. Respiratory bronchiolitis, respiratory bronchiolitis-associated interstitial lung disease, and desquamative interstitial pneumonia: different entities or part of the spectrum of the same disease process? , 1999, AJR. American journal of roentgenology.
[165] K. Moriyama,et al. Interferon‐γ inhibits the myofibroblastic phenotype of rat palatal fibroblasts induced by transforming growth factor‐β1 in vitro , 1999 .
[166] N. Kaminski,et al. The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. , 1999, Cell.
[167] G. Raghu,et al. Treatment of Idiopathic Pulmonary Fibrosis with a New Antifibrotic Agent , Pirfenidone Results of a Prospective , Open-label Phase II Study , 1999 .
[168] T. Michele,et al. The clinical management of sarcoidosis. A 50-year experience at the Johns Hopkins Hospital. , 1999, Medicine.
[169] Y. Soini,et al. Apoptotic Activity is Increased in the Newly Formed Fibromyxoid Connective Tissue in Bronchiolitis Obliterans Organizing Pneumonia , 1999, Lung.
[170] A. Singer,et al. Cutaneous wound healing. , 1999, The New England journal of medicine.
[171] G Murphy,et al. Proteolysis and cell migration: creating a path? , 1999, Current opinion in cell biology.
[172] M. Burdick,et al. IFN-gamma-inducible protein-10 attenuates bleomycin-induced pulmonary fibrosis via inhibition of angiogenesis. , 1999, Journal of immunology.
[173] A. Woodcock,et al. The detection of Epstein-Barr virus DNA in lung tissue from patients with idiopathic pulmonary fibrosis. , 1999, American journal of respiratory and critical care medicine.
[174] G. Gurujeyalakshmi,et al. Pirfenidone inhibits PDGF isoforms in bleomycin hamster model of lung fibrosis at the translational level. , 1999, American journal of physiology. Lung cellular and molecular physiology.
[175] Y. Kaneda,et al. Hepatocyte growth factor gene therapy of liver cirrhosis in rats , 1999, Nature Medicine.
[176] Karen P. Demick,et al. Analysis of interferon‐γ‐dependent and ‐independent pathways of macrophage activation , 2000, Journal of leukocyte biology.
[177] G. Laurent,et al. Adult familial cryptogenic fibrosing alveolitis in the United Kingdom , 2000, Thorax.
[178] M. Selman,et al. TIMP-1, -2, -3, and -4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvironment? , 2000, American journal of physiology. Lung cellular and molecular physiology.
[179] David A. Lynch,et al. Idiopathic pulmonary fibrosis: Diagnosis and treatment: International Consensus Statement , 2000 .
[180] J. Samet,et al. Occupational and environmental risk factors for idiopathic pulmonary fibrosis: a multicenter case-control study. Collaborating Centers. , 2000, American journal of epidemiology.
[181] M. Selman,et al. Surfactant components modulate fibroblast apoptosis and type I collagen and collagenase-1 expression. , 2000, American journal of physiology. Lung cellular and molecular physiology.
[182] M. Gaxiola,et al. Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD. , 2000, Chest.
[183] D. Schroeder,et al. Idiopathic pulmonary fibrosis: Impact of oxygen and colchicine, prednisone, or no therapy on survival. , 2000, American journal of respiratory and critical care medicine.
[184] Lokshina Ss,et al. Viruses and idiopathic pulmonary fibrosis. , 2000 .
[185] K. Brew,et al. Tissue inhibitors of metalloproteinases: evolution, structure and function. , 2000, Biochimica et biophysica acta.
[186] 西山 理. Serial high resolution CT findings in nonspecific interstitial pneumonia/fibrosis , 2001 .
[187] R. Bois. The Genetic Predisposition to Interstitial Lung Disease , 2002 .
[188] M. Schwarz,et al. Interstitial Lung Disease , 2003 .